Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,319 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Active, Not Recruiting

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

NCT06134362

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Almagro, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Francistown, Botswana
  • GSK Investigational Site Porto Alegre, Brazil
View all 33 locations
View Trial Details
Active, Not Recruiting

Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

NCT06317051

Conditions
Blood-Borne Infections, Body Weight, Body Weight Changes, +16 more
Locations
  • Hospital Ramos Mejía Buenos Aires, Argentina
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Austin Health Melbourne, Victoria, Australia
  • CART-CRS Chennai, Tamil Nadu, India
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

NCT02951052

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 113 locations
View Trial Details
Active, Not Recruiting

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

NCT03296202

Conditions
Antiretroviral Agents, Blood-Borne Infections, Communicable Diseases, +12 more
Locations
  • service de médecine interne - CH d'Agen Agen, France
  • Médecine interne - CH d'Angoulême Angoulême, France
  • service de maladies infectieuses - CH de la Côte Basque Bayonne, France
  • service de médecine inter et maladies infectieuses - Hopital Saint André Bordeaux, France
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

NCT05979311

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Ciudad Autonoma de Buenos Aire, Argentina
  • GSK Investigational Site Córdoba, Argentina
  • GSK Investigational Site Antwerp, Belgium
  • GSK Investigational Site Brussels, Belgium
View all 64 locations
View Trial Details
Active, Not Recruiting

Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.

NCT06694753

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Setshaba Research Centre CRS Soshanguve, Gauteng, South Africa
  • Perinatal HIV Research Unit (PHRU) Soweto, Gauteng, South Africa
  • CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Isipingo CRS Isipingo, KwaZulu-Natal, South Africa
View Trial Details

Related conditions